Qingqiao Song

689 total citations
29 papers, 395 citations indexed

About

Qingqiao Song is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Qingqiao Song has authored 29 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 3 papers in Nephrology. Recurrent topics in Qingqiao Song's work include Cardiovascular Function and Risk Factors (6 papers), Heart Failure Treatment and Management (5 papers) and Cardiac Fibrosis and Remodeling (5 papers). Qingqiao Song is often cited by papers focused on Cardiovascular Function and Risk Factors (6 papers), Heart Failure Treatment and Management (5 papers) and Cardiac Fibrosis and Remodeling (5 papers). Qingqiao Song collaborates with scholars based in China. Qingqiao Song's co-authors include Bingxuan Zhang, Huaqin Wu, Shuqing Shi, Jiayu Lv, Xia Xu, Yuanhui Hu, Yajiao Wang, Yumeng Li, Yumeng Li and Huan Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Ethnopharmacology and Frontiers in Pharmacology.

In The Last Decade

Qingqiao Song

27 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingqiao Song China 12 162 108 45 41 37 29 395
Huaqin Wu China 12 150 0.9× 127 1.2× 36 0.8× 55 1.3× 35 0.9× 34 412
Huiyan Qu China 12 219 1.4× 99 0.9× 41 0.9× 32 0.8× 29 0.8× 29 366
Bingxuan Zhang China 12 115 0.7× 87 0.8× 37 0.8× 37 0.9× 29 0.8× 28 358
Biao Xu China 11 201 1.2× 106 1.0× 75 1.7× 47 1.1× 44 1.2× 17 445
Fenghe Du China 13 116 0.7× 98 0.9× 41 0.9× 59 1.4× 60 1.6× 28 386
Hongwei Ye China 12 180 1.1× 72 0.7× 31 0.7× 66 1.6× 31 0.8× 33 373
Shi-Hao Ni China 9 206 1.3× 73 0.7× 41 0.9× 46 1.1× 39 1.1× 40 449
Asmaa M. A. Bayoumi Egypt 13 112 0.7× 72 0.7× 26 0.6× 39 1.0× 38 1.0× 26 408
Dongqi An China 7 163 1.0× 161 1.5× 43 1.0× 66 1.6× 41 1.1× 11 398
Hengdao Liu China 12 183 1.1× 62 0.6× 51 1.1× 72 1.8× 74 2.0× 26 399

Countries citing papers authored by Qingqiao Song

Since Specialization
Citations

This map shows the geographic impact of Qingqiao Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingqiao Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingqiao Song more than expected).

Fields of papers citing papers by Qingqiao Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingqiao Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingqiao Song. The network helps show where Qingqiao Song may publish in the future.

Co-authorship network of co-authors of Qingqiao Song

This figure shows the co-authorship network connecting the top 25 collaborators of Qingqiao Song. A scholar is included among the top collaborators of Qingqiao Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingqiao Song. Qingqiao Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Jiayu, Yajiao Wang, Bingxuan Zhang, et al.. (2025). Lingguizhugan decoction ameliorates renal injury secondary to heart failure by improving pyroptosis through TLR4/NF-KB/IRE1α pathway. Phytomedicine. 143. 156862–156862. 2 indexed citations
2.
3.
Shi, Shuqing, et al.. (2025). Integrative UHPLC-HRMS and computational biology reveal ferroptosis and anoikis targeting by Wenpitongluo decoction in cardiorenal syndrome. Frontiers in Chemistry. 13. 1617676–1617676. 1 indexed citations
4.
5.
Shi, Shuqing, et al.. (2024). Association of systemic inflammatory markers with clinical adverse prognosis and outcomes in HFpEF: a systematic review and meta-analysis of cohort studies. Frontiers in Cardiovascular Medicine. 11. 1461073–1461073. 4 indexed citations
6.
Zhu, Xueping, Meng Lv, Tao Cheng, et al.. (2024). Bibliometric analysis of atrial fibrillation and ion channels. Heart Rhythm. 21(7). 1161–1169. 3 indexed citations
7.
Wang, Yajiao, Shuqing Shi, Yumeng Li, et al.. (2024). Linking abnormal fat distribution with HFpEF and diastolic dysfunction: a systematic review, meta-analysis, and meta-regression of observational studies. Lipids in Health and Disease. 23(1). 277–277. 4 indexed citations
8.
Wang, Yajiao, Shuqing Shi, Xia Xu, et al.. (2023). SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules. SHILAP Revista de lepidopterología. 2. 1109321–1109321. 5 indexed citations
9.
Wang, Yajiao, Shuqing Shi, Yumeng Li, et al.. (2023). Blood urea nitrogen to creatinine ratio and long-term survival in patients with chronic heart failure. European journal of medical research. 28(1). 343–343. 13 indexed citations
10.
Xu, Xia, Bingxuan Zhang, Yajiao Wang, et al.. (2023). Renal fibrosis in type 2 cardiorenal syndrome: An update on mechanisms and therapeutic opportunities. Biomedicine & Pharmacotherapy. 164. 114901–114901. 11 indexed citations
11.
Lv, Jiayu, Shuqing Shi, Xia Xu, et al.. (2023). Effects of garlic supplementation on components of metabolic syndrome: a systematic review, meta-analysis, and meta-regression of randomized controlled trials. BMC Complementary Medicine and Therapies. 23(1). 260–260. 9 indexed citations
12.
Shi, Shuqing, Xinxin Mao, Jiayu Lv, et al.. (2023). Qi-Po-Sheng-Mai granule ameliorates Ach-CaCl2 -induced atrial fibrillation by regulating calcium homeostasis in cardiomyocytes. Phytomedicine. 119. 155017–155017. 13 indexed citations
13.
Lv, Jiayu, Yumeng Li, Shuqing Shi, et al.. (2022). Frontier and Hotspot Evolution in Cardiorenal Syndrome: A Bibliometric Analysis From 2003 to 2022. Current Problems in Cardiology. 48(8). 101238–101238. 14 indexed citations
14.
Shi, Shuqing, Bingxuan Zhang, Yumeng Li, et al.. (2022). Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome. Frontiers in Cardiovascular Medicine. 9. 837270–837270. 15 indexed citations
15.
Xue, Wenjing, Shuqing Shi, Yuan Li, et al.. (2022). Cardiac Remodeling in Heart Failure: Role of Pyroptosis and Its Therapeutic Implications. Frontiers in Cardiovascular Medicine. 9. 870924–870924. 41 indexed citations
16.
Xu, Xia, Yumeng Li, Shuqing Shi, et al.. (2022). The Application of Angiotensin Receptor Neprilysin Inhibitor in Cardiovascular Diseases: A Bibliometric Review From 2000 to 2022. Frontiers in Cardiovascular Medicine. 9. 899235–899235. 8 indexed citations
17.
Lv, Jiayu, Shuqing Shi, Bingxuan Zhang, et al.. (2022). Role of puerarin in pathological cardiac remodeling: A review. Pharmacological Research. 178. 106152–106152. 43 indexed citations
18.
Shi, Shuqing, Jiayu Lv, Wenjing Xue, et al.. (2022). Opportunities and Challenges in Cardio-Oncology: A Bibliometric Analysis From 2010 to 2022. Current Problems in Cardiology. 48(8). 101227–101227. 27 indexed citations
19.
20.
Wang, Xiaoling, Jiliang Fang, Qing Zhao, et al.. (2012). High-pitch dual-source CT coronary angiography: analysis of the impact on image quality of altered electrocardiography waves during data acquisition. International journal of cardiac imaging. 28(S1). 15–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huaqin Wu Breakdown of academic impact, for papers by Huiyan Qu Breakdown of academic impact, for papers by Bingxuan Zhang Breakdown of academic impact, for papers by Biao Xu Breakdown of academic impact, for papers by Fenghe Du Breakdown of academic impact, for papers by Hongwei Ye Breakdown of academic impact, for papers by Shi-Hao Ni Breakdown of academic impact, for papers by Asmaa M. A. Bayoumi Breakdown of academic impact, for papers by Dongqi An Breakdown of academic impact, for papers by Hengdao Liu
Rankless by CCL
2026